| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $63K | — | — |
| SG&A Expense | $653K | — | +153.9% |
| Interest Expense | $80K | — | -28.0% |
| Pre-tax Income | -$1.5M | — | -43.6% |
| Net Income | -$1.5M | — | -43.6% |
| EPS (Basic) | -$0.07 | — | +50.0% |
| EPS (Diluted) | -$0.07 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $9.9M | -21.9% | +179.2% |
| Total Assets | $12.3M | -16.6% | +232.5% |
| Current Liabilities | $6.3M | -13.8% | +202.1% |
| Total Liabilities | $10.2M | -10.0% | +386.1% |
| Stockholders' Equity | $2.1M | -38.5% | +31.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$842K | — | +52.3% |
| Investing Cash Flow | $2.8M | — | — |
| Financing Cash Flow | -$2.1M | — | -139.7% |